PHARMALA BIOTECH
PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.
PHARMALA BIOTECH
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.pharmala.ca
Total Employee:
1+
Status:
Active
Contact:
+1 855 444 6362
Email Addresses:
[email protected]
Official Site Inspections
http://www.pharmala.ca Semrush global rank: 9.39 M Semrush visits lastest month: 165
- Host name: 104.248.104.88
- IP address: 104.248.104.88
- Location: Toronto Canada
- Latitude: 43.6547
- Longitude: -79.3623
- Timezone: America/Toronto
- Postal: M5A
More informations about "PharmAla Biotech"
PharmAla Biotech | PharmAla granted a Controlled Drugs ... - English
PharmAla Biotech Holdings Inc. (CSE: MDMA) is a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules, including MDMA. …See details»
PharmAla Biotech | Media
PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel Posted: Jan 20, 2025 PharmAla Issues Audited …See details»
PharmAla granted a Controlled Drugs & Substances ... - Financial …
Jan 25, 2024 PharmAla’s research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. PharmAla is a …See details»
PharmAla granted a Controlled Drugs & Substances Dealer’s
Jan 25, 2024 PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with …See details»
PharmAla Biotech - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +1 855 444 6362; PharmAla Biotech is a Canadian biotechnology company that specialises in the research, development, …See details»
PharmAla named an Intellectual Property Ontario Client
Feb 22, 2024 PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with …See details»
PharmAla Biotech First Publicly Traded Company to Produce
Aug 17, 2022 For more information, please visit www.PharmAla.ca, where you can sign up to receive regular new updates. ... Organization Profile. PharmAla Biotech Inc. Contact Cision. …See details»
PharmAla Contracts with Partner to Act as US Distributor
Mar 24, 2025 Email: [email protected] Phone: 1-855-444-6362 Website: www.PharmAla.ca. ... including ALA-002, its lead drug candidate. PharmAla is a “regulatory first” organization, …See details»
PharmAla Biotech ready to assist Alberta Government …
Oct 6, 2022 For more information, visit www.PharmAla.ca. ... Organization Profile. PharmAla Biotech Inc. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a Client; Request a Demo ...See details»
PharmAla Biotech | PharmAla Biotech and Filament Health
PharmAla Biotech Holdings Inc. (CSE: MDMA) is a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules, including MDMA. …See details»
PharmAla Biotech | PharmAla Launches Prescriber’s Portal ... - English
PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with regulators. Our …See details»
PharmAla Reaches Agreement in Principle to Supply MDMA to …
Nov 14, 2024 Qualified researchers may contact [email protected]. Issuance of Shares for Debt Settlement. In addition, as previously announced, the Company has settled $100,000 of …See details»
PharmAla Granted a Controlled Drugs & Substances Dealer’s …
Jan 25, 2024 PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with …See details»
Pharmala Biotech Holdings Inc. - Canadian Securities Exchange
Jan 11, 2022 pharmala.ca. Social. ... Pharmala also intends to undertake development of novel formulations of MDMA and the MDXX class of compounds, as well as developing novel drug …See details»
PharmAla to supply Johns Hopkins Medicine for Clinical Trial
Sep 11, 2024 PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with …See details»
About NAPRA: Short Introductory Presentation - NAPRA
Mar 19, 2025 Collaborating with federal and other national and international organizations on behalf of all PRAs. ... Phone: 1 (613) 569-9658 [email protected]. Subscribe to Updates from …See details»
PharmAla Biotech Completes Annual General Meeting
PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with regulators. Our …See details»
PharmAla Launches Prescriber’s Portal for Medical Professionals …
May 3, 2024 PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with …See details»
PharmAla Biotech | PharmAla Issues Audited Financial Statements ...
All figures are reported in Canadian dollars. The Company’s full set of consolidated audited financial statements for the years ended August 31, 2024 and 2023 and accompanying …See details»
PharmAla Reaches Agreement in Principle to Supply MDMA to …
TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“See details»